AGIO — Agios Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapTurnaround

Annual balance sheet for Agios Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	573	1,020	783	777	894
Net Total Accounts Receivable
Net Total Receivables	25.4	4.38	2.21	2.81	4.11
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	637	1,064	833	834	966
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	118	104	88.1	69.8	54.6
Long Term Investments
Other Long Term Assets
Total Assets	853	1,438	1,239	937	1,663
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	94.4	59.8	62.6	68	81.2
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	453	146	138	126	122
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	400	1,292	1,101	811	1,541
Total Liabilities & Shareholders' Equity	853	1,438	1,239	937	1,663
Total Common Shares Outstanding
Total Preferred Shares Outstanding